Question 5 A(v) the risk‐mitigating measures and, where relevant, surveillance of the disease are effective and proportionate to the risks posed by the disease in the Union Answer Y ☐ N ☐ na ☐ | ||
---|---|---|
Article 7 criteria | Article 7 parameters | Assessment of the Article 7 parameters from fact sheet |
(a)(viii) Existence of diagnostic and disease control tools | (a)(viii) 1 Existence of diagnostic tools | <Information from the fact sheet> |
(a)(viii) 2 Existence of disease control tools | <Information from the fact sheet> | |
(b)(ii) Impact of the disease on human health | (b)(ii) 7 Availability of medical treatment and their effectiveness (therapeutic effect and any resistance) | <Information from the fact sheet> |
(b)(ii) 8 Availability of vaccines and their effectiveness (reduced morbidity) | ||
(d)(i) Feasibility, availability and effectiveness of diagnostic tools and capacities | (d)(i) 1 officially/internationally recognised diagnostic tool, OIE certified | <Information from the fact sheet> |
(d)(i) 2 Se and Sp of diagnostic test | <Information from the fact sheet> | |
(d)(i) 3 type of sample matrix to be tested (blood, tissue, etc.) | <Information from the fact sheet> | |
(d)(ii) Feasibility, availability and effectiveness of vaccination | (d)(ii) 1 types of vaccines available on the market | <Information from the fact sheet> |
(d)(ii) 2 availability/production capacity (per year) | <Information from the fact sheet> | |
(d)(ii) 3 Field protection as reduced morbidity (reduced susceptibility to infection and/or to disease) | <Information from the fact sheet> | |
(d)(ii) 4 Duration of protection | <Information from the fact sheet> | |
(d)(ii) 5 Way of administration | <Information from the fact sheet> | |
(d)(iii) Feasibility, availability and effectiveness of medical treatments | (d)(iii) 1 types of drugs available on the market and/or allowed by the EU regulatory system | <Information from the fact sheet> |
(d)(iii) 2 availability/production capacity (per year) | <Information from the fact sheet> | |
(d)(iii) 3 therapeutic effect in the field (effectiveness) | ||
(d)(iii) 4 Way of administration | ||
(d)(iv) Feasibility, availability and effectiveness of biosecurity measures | (d)(iv) 1 available biosecurity measures | <Information from the fact sheet> |
(d)(iv) 2 effectiveness of biosecurity measure (description) | <Information from the fact sheet> | |
(d)(iv) 3 feasibility of biosecurity measure (description) | <Information from the fact sheet> | |
(d)(v) Feasibility, availability and effectiveness of restrictions on the movement of animals and products, as control measure | (d)(v) 1 available restriction movement measures | <Information from the fact sheet> |
(d)(v) 2 effectiveness of restriction of animal movement in preventing the between farm spread (description) | <Information from the fact sheet> | |
(d)(v) 3 feasibility of restriction of animal movement (description) | <Information from the fact sheet> | |
(d)(vi) Feasibility, availability and effectiveness of killing of animals | (d)(vi) 1 available killing of animal measures | <Information from the fact sheet> |
(d)(vi) 2 effectiveness of killing animals (at farm level or within the farm) for reducing/stopping spread of the disease (description) | <Information from the fact sheet> | |
(d)(vi) 3 feasibility of killing animals (description) | <Information from the fact sheet> | |
(d)(vii) feasibility, availability and Effectiveness of disposal of carcasses and other relevant animal by‐products | (d)(vii) 1 disposal options available | <Information from the fact sheet> |
(d)(vii) 2 effectiveness of disposal option (description) | <Information from the fact sheet> | |
(d)(vii) 3 feasibility of disposal option (description) | <Information from the fact sheet> |